Clinical utility of [18F]FDG PET/CT in the assessment of mediastinal lymph node disease after neoadjuvant chemoimmunotherapy for non-small cell lung cancer

Objectives The performance of positron emission tomography/computed tomography (PET/CT) for the prediction of ypN2 disease in non-small cell lung cancer (NSCLC) after neoadjuvant chemoimmunotherapy has not been reported. This multicenter study investigated the utility of PET/CT to assess ypN2 diseas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European radiology 2023-12, Vol.33 (12), p.8564-8572
Hauptverfasser:	Zhang, Lei, E, Haoran, Huang, Jia, Wu, Junqi, Li, Qiang, Hou, Likun, Li, Chongwu, Dai, Chenyang, Deng, Jiajun, Yang, Minglei, Ma, Minjie, Ren, Yijiu, Luo, Qingquan, Zhao, Deping, Chen, Chang
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemotherapy Chest Computed tomography Diagnostic Radiology Disease Fluorine isotopes Imaging Internal Medicine Interventional Radiology Invasiveness Lung cancer Lung diseases Lymph nodes Medicine Medicine & Public Health Neuroradiology Non-small cell lung carcinoma Patients Performance evaluation Positron emission Positron emission tomography Radiology Risk factors Small cell lung carcinoma Survival analysis Tomography Ultrasound
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!